Literature DB >> 20336765

Effect of bone graft substitute on marrow stromal cell proliferation and differentiation.

Kevin Siggers1, Hanspeter Frei, Göran Fernlund, Fabio Rossi.   

Abstract

Marrow stromal cells (MSCs) are ideally suited for tissue engineered bone grafts since they have the potential to regenerate bone, but may also maintain the homeostasis of the repaired tissue through their ability for self-renewal. An ideal bone graft substitute should support MSC self-renewal as well as differentiation to ensure complete bone defect regeneration and maintenance. The purpose of this investigation was to determine the effect of different substrate materials on MSC expansion and differentiation. Calcium polyphosphate (CPP), bone and hydroxyapatite/tricalcium phosphate (HA/TCP) were seeded with rat MSCs and maintained in culture conditions that promote cell expansion. At 0, 3, 7, 14, and 21 days cell numbers were determined by measuring their metabolic activity using a MTT assay and the frequency of cycling cells by 24 hr BrdU incorporation. Osteogenic, chondrogenic, and adipogenic marker expression in these cultures was measured by qRT-PCR. An initial drop in cell numbers was observed on all substrates. CPP and bone, but not HA/TCP supported an increase in proliferating cells at day 14 and 21. In addition, no upregulation of mature bone markers was observed in cells cultured on CPP and bone, which suggests that these substrates support the expansion of undifferentiated MSCs. In contrast, cell numbers on HA/TCP decreased with time and only rare BrdU positive cells were observed. This decrease in proliferation correlated with the down regulation of osteogenic progenitor markers and the substantial increase in mature osteocyte markers, indicating that HA/TCP favors MSC differentiation and maturation along the osteogenic lineage. (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336765     DOI: 10.1002/jbm.a.32766

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  3 in total

1.  Benefits of biphasic calcium phosphate hybrid scaffold-driven osteogenic differentiation of mesenchymal stem cells through upregulated leptin receptor expression.

Authors:  Chi-Chien Niu; Song-Shu Lin; Wen-Jer Chen; Shih-Jung Liu; Lih-Huei Chen; Chuen-Yung Yang; Chao-Jan Wang; Li-Jen Yuan; Po-Han Chen; Hsiao-Yang Cheng
Journal:  J Orthop Surg Res       Date:  2015-07-16       Impact factor: 2.359

2.  Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment.

Authors:  Stefano Giannotti; Luisa Trombi; Vanna Bottai; Marco Ghilardi; Delfo D'Alessandro; Serena Danti; Giacomo Dell'Osso; Giulio Guido; Mario Petrini
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

3.  Surgical sutures filled with adipose-derived stem cells promote wound healing.

Authors:  Ann Katharin Reckhenrich; Bianca Manuela Kirsch; Elizabeth Ann Wahl; Thilo Ludwig Schenck; Farid Rezaeian; Yves Harder; Peter Foehr; Hans-Günther Machens; José Tomás Egaña
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.